Table 2.
Association of non-antidiabetic drugs with hypoglycaemia in the French pharmacovigilance database, in reports including or not including antidiabetic agents
| All reports | Hypoglycaemia | ROR* | 95% CI† | ||
|---|---|---|---|---|---|
| Reports including ADAs | 3 469 | 299 | – | – | – |
| ARB‡ | 275 | 11 | 0.4 | 0.2 | 0.8 |
| ACEI§ | 336 | 31 | 1 | 0.7 | 2 |
| Atenolol | 154 | 7 | 0.5 | 0.2 | 1 |
| DHP¶ | 248 | 12 | 0.5 | 0.3 | 0.9 |
| Frusemide | 666 | 48 | 0.8 | 0.6 | 1 |
| Cibenzoline | 13 | 4 | 5 | 2 | 16 |
| Reports not including ADAs | 171 126 | 508 | – | – | – |
| ARBs‡ | 2 234 | 10 | 2 | 0.8 | 3 |
| ACEIs§ | 2 366 | 8 | 1 | 0.6 | 2 |
| Atenolol | 1 806 | 12 | 2 | 1 | 4 |
| DHP¶ | 2 122 | 10 | 2 | 1 | 3 |
| Frusemide | 7 173 | 45 | 2.2 | 2 | 3 |
| Cibenzoline | 167 | 53 | 174 | 124 | 244 |
ROR, reporting odds ratio of association of selected drug with hypoglycaemia (see Table 2).
95% CI, lower and upper limits of 95% confidence interval for OR.
ARBs, angiotensin receptor blockers (losartan or irbesartan).
ACEIs, angiotensin converting enzyme inhibitor (enalapril or captopril).
DHP, dihydropyridines (nifedipine, nicardipine, nitrendipine, nimodipine).